Uniphar (LON:UPR) Hits New 52-Week High – Still a Buy?

Posted by Linda Flegge on May 14th, 2025

Uniphar plc (LON:UPR – Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as GBX 284 ($3.78) and last traded at GBX 279.09 ($3.71), with a volume of 1825 shares trading hands. The stock had previously closed at GBX 280 ($3.73).

Wall Street Analyst Weigh In

Separately, Shore Capital reissued a “buy” rating on shares of Uniphar in a research report on Tuesday, February 25th.

View Our Latest Stock Report on Uniphar

Uniphar Trading Down 0.0%

The company has a market cap of £858.83 million, a PE ratio of 19.18 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The company has a 50 day simple moving average of GBX 235.70 and a two-hundred day simple moving average of GBX 203.07.

Uniphar Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, May 16th. Shareholders of record on Thursday, April 24th will be given a €0.01 ($0.01) dividend. This is a positive change from Uniphar’s previous dividend of $0.01. This represents a yield of 0.47%. The ex-dividend date of this dividend is Thursday, April 24th. Uniphar’s dividend payout ratio is presently 13.91%.

Uniphar Company Profile

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.